DMG-mPEG2000 (CAS 160743-62-4) Comprehensive User Guide
Contents
- 1. Product Specifications & Comparative Analysis
- 2. Functional Applications
- 3. Implementation Scenarios
- 4. Verified Case Studies
- 5. Procurement Guidance
1. Product Specifications & Comparative Analysis
| Parameter | DMG-mPEG2000 | Conventional PEG Derivatives |
|---|---|---|
| CAS Number | 160743-62-4 | Varies |
| Molecular Weight | 2000 Da ± 3% | 1500-5000 Da |
| PEG Chain Length | 45 ethylene oxide units | Variable units |
| Critical Micelle Concentration | 0.005-0.015 mM | 0.02-0.05 mM |
2. Functional Applications
Primary industrial implementations:
- Lipid nanoparticle (LNP) stabilization
- mRNA vaccine encapsulation
- Targeted drug delivery systems
- Controlled release formulations
3. Implementation Scenarios
Typical operational protocols:
- Nanoparticle self-assembly: 0.5-2% w/v concentration
- Solvent system: Ethanol/water (7:3 ratio)
- Optimal pH range: 6.8-7.4
4. Verified Case Studies
Case 1: PharmaTech Inc. (2023)
- Application: siRNA delivery optimization
- Result: 62% gene silencing efficiency
- Dosage: 15mg/kg body weight
Case 2: BioGen Solutions (2022)
- Application: Oncolytic virus stabilization
- Result: 3x longer half-life
- Storage: -80°C lyophilized form
5. Procurement Guidance
Technical consultation contact:
| Contact Method | Detail |
|---|---|
| info@vivalr.com | |
| Phone | (86) 15866781826 |
| Lead Time | 3-5 business days |
Request product specification sheet: Click-to-email



评论
目前还没有评论。